Familial predisposition to monoclonal gammopathy of unknown significance, Waldenström's macroglobulinemia, and multiple myeloma

Clinical Lymphoma and Myeloma

Volumn 9, Issue 1, 2009, Pages 27-29

  Ögmundsdóttir, Helga ^a   Einarsdóttir, Helga ^a   Steingrímsdóttir, Hlíf ^a,b   Haraldsdóttir, Vilhelmína ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Non Hodgkin lymphoma; Polyclonal serum IgM; Waldenstr m

Indexed keywords

IMMUNOGLOBULIN; POKEWEED MITOGEN; PROTEIN BCL 2;

ARTICLE; B LYMPHOCYTE; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; CELL SURVIVAL; DISEASE PREDISPOSITION; FAMILIAL DISEASE; FAMILY; GENETIC ANALYSIS; HUMAN; ICELAND; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PERIPHERAL LYMPHOCYTE; POPULATION RESEARCH; WALDENSTROEM MACROGLOBULINEMIA; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; PARAPROTEINEMIA;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MULTIPLE MYELOMA; PARAPROTEINEMIAS; WALDENSTROM MACROGLOBULINEMIA;

EID: 67649525696     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2009.n.005     Document Type: Article

References (15)

1. Ogmundsdottir HM. Pathogenesis of immunoglobulin-producing neoplasias -lessons from family studies. Res Adv in Blood 2003; 2:15-23.
2. Engelhardt M, Ihorst G, Behringer D, et al. Incidence of monoclonal B-cell disease in siblings of patients with multiple myeloma. Haematologica 2006; 91:274-6.
3. Lynch HT, Ferrara K, Barlogie B, et al. Familial myeloma. N Engl J Med 2008; 359:152-7.
4. McMaster ML. Familial Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30:146-52.
5. McMaster ML, Csako G, Giambarresi TR, et al. Long-term evaluation of three multiple-case Waldenstrom macroglobulinemia families. Clin Cancer Res 2007; 13:5063-9.
6. McMaster ML, Goldin LR, Bai Y, et al. Genomewide linkage screen for Waldenstrom macroglobulinemia susceptibility loci in high-risk families. Am J Hum Genet 2006; 79:695-701.
7. Treon SP, Hunter ZR, Aggarwal A, et al. Characterization of familial Waldenstrom's macroglobulinemia. Ann Oncol 2006; 17:488-94.
8. Deshpande HA, Hu XP, Marino P, et al. Anticipation in familial plasma cell dyscrasias. Br J Haematol 1998; 103:696-703.
9. Fine JM, Blatrix C, Marneux M, et al. [Monoclonal gammapathy of a familial type. Discovery of myeloma in the sister of a patient suffering from Waldenstrom's macroglobulinemia]. Nouv Presse Med 1976; 5:2694-6.
10. Ogmundsdottir HM, Haraldsdottir V, Johannesson GM, et al. Familiality of benign and malignant paraproteinemias. A population-based cancer-registry study of multiple myeloma families. Haematologica 2005; 90:66-71.
11. Kristinsson SY, Bjorkholm M, Goldin LR, et al. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. Blood 2008; 112:3052-6.
12. Bjornsson OG, Arnason A, Gudmundsson S, et al. Macroglobulinaemia in an Icelandic family. Acta Med Scand 1978; 203:283-8.
13. Ogmundsdottir HM, Johannesson GM, Sveinsdottir S, et al. Familial macroglobulinaemia: hyperactive B-cells but normal natural killer function. Scand J Immunol 1994; 40:195-200.
14. Ogmundsdottir HM, Sveinsdottir S, Sigfusson A, et al. Enhanced B cell survival in familial macroglobulinaemia is associated with increased expression of Bcl-2. Clin Exp Immunol 1999; 117:252-60.
15. Gould TD, Gottesman, II. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav 2006; 5:113-9.